PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE
May 1, 2005, 00:00
10.1016/S1098-3015(10)62953-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)62953-1/fulltext
Title :
PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62953-1&doi=10.1016/S1098-3015(10)62953-1
First page :
Section Title :
Open access? :
No
Section Order :
390